Sep 17 2010
Jose Mir, President of SensiVida Medical Technologies proclaimed that, their company which manufactures painless bio-medical diagnostic equipments, has been granted the JumpStart project funding from the Cornell Center for Materials Research (CCMR) for the last quarter of 2010.
The JumpStart schemes financially supported by the New York State Foundation for Science, Technology and Innovation (NYSTAR), allows businesses to function in association with the faculty on the basic aspects of growing technologies in the field of materials science. The CCMR scheme selects projects with the highest capability for generating reciprocally advantageous, lasting bond with Cornell University.
SensiVida Medical Technologies is advancing a pain-free biomedical glucose monitor for diabetic people and individuals at high risk, which automatically furnishes precise, timely monitoring of their glucose levels in the blood, eliminating blood extraction process and allowing them to modify their diets, lifestyles and medication. The highly-advanced diagnostic technology will facilitate test observance and will remarkably enhance the prolonged health status and life’s quality.
Researchers at SensiVida will be collaborating with Antje Baeumner, Professor at Cornell University, who has intense knowledge in the field of nanotechnology and biosensors, for learning the reproducibility and stability of materials in choosing the highly-secure chemical sensors for improving the glucose monitor.
Jose Mir explained that the researchers at SensiVida are very enthusiastic to work with Professor Baeumner who chaired the Gordon Research Conference on Bioanalytical Sensors, 2010 and published numerous valuable publications in the field of micro-Total Analysis Systems and biosensors. Professor Baeumner has been awarded $5 Million for her research projects and has guided nearly 30 graduates and more than 60 undergraduates in her research team.
Dr. Baeumner remarked that the joint venture will provide insights into the basic material research and will facilitate the commercialization of innovative biosensors of SensiVida. She added by saying that this collaboration will strengthen the prolonged research bonding with SensiVida and Baeumner Biosensors and Bioanalytical Microsystems Laboratory.
Source: http://www.sensividamedtech.com